Perspectives

Multivalent gamma-delta T-cells: promising agents for the treatment of cancers 0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
Results from a Phase I trial of rapidly manufactured Prgn-3006 Ultracar-T in R/R AML 2:08
Results from a Phase I trial of rapidly manufactured Prgn-3006 Ultracar-T in R/R AML
David Sallman • 11 Dec 2022
Implementing automation technology in the CGT space 1:28
Implementing automation technology in the CGT space
Saskia Rösch • 6 Apr 2022
Enhancing the long-term functionality of CAR-T cells in solid tumors 1:23
Enhancing the long-term functionality of CAR-T cells in solid tumors
Shigeki Yagyu • 8 Apr 2022
Improving the efficiency of cancer vaccines with adoptive T cell therapy approaches 1:33
Improving the efficiency of cancer vaccines with adoptive T cell therapy approaches
Chiara Bonini • 1 Apr 2022
Highlights in the field of Treg cells from ICLE 2022 0:42
Highlights in the field of Treg cells from ICLE 2022
Michael Traxlmayr • 1 Apr 2022
Adoptive T cell therapies for solid tumors: what are the key challenges? 1:38
Adoptive T cell therapies for solid tumors: what are the key challenges?
Chris Klebanoff • 1 Apr 2022
The use of CRISPR-Cas9 technology in the development of T cell therapies 0:55
The use of CRISPR-Cas9 technology in the development of T cell therapies
Alessio Nahmad • 31 Mar 2022
Unanswered questions in developing engineered T cells for solid tumors 2:35
Unanswered questions in developing engineered T cells for solid tumors
Elvira D’Ippolito • 31 Mar 2022
Novel approaches in lymphocyte engineering 3:31
Novel approaches in lymphocyte engineering
Elvira D’Ippolito • 31 Mar 2022
Updates in cell and gene therapy approvals 1:27
Updates in cell and gene therapy approvals
Bruce Levine • 27 Jan 2022
Trends and innovations within the advanced therapy sector 1:12
Trends and innovations within the advanced therapy sector
Bruce Levine • 27 Jan 2022
Challenges in manufacturing viral vectors for the clinic 4:51
Challenges in manufacturing viral vectors for the clinic
Nathalie Clement • 27 Jan 2022
Strategies to increase cell therapy manufacturing capabilities 1:25
Strategies to increase cell therapy manufacturing capabilities
Shannon Eaker • 27 Jan 2022
Patient-centric innovations in the supply chain 2:00
Patient-centric innovations in the supply chain
Julia Tarasenko • 26 Jan 2022
Digitization in the advanced therapy sector 3:43
Digitization in the advanced therapy sector
Shannon Eaker • 27 Jan 2022
The content of VJRegenMed is intended for healthcare professionals